Detalles de la búsqueda
1.
The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
Mol Med
; 28(1): 78, 2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35836112
2.
[Changes in the penis size of prostate cancer patients after radical prostatectomy and its influencing factors].
Zhonghua Nan Ke Xue
; 27(6): 522-525, 2021 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-34914292
3.
The Value of 99mTc-PSMA SPECT/CT-Guided Surgery for Identifying and Locating Lymph Node Metastasis in Prostate Cancer Patients.
Ann Surg Oncol
; 26(2): 653-659, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30324468
4.
[Attitudes of prostate cancer patients towards postoperative penile rehabilitation and their influencing factors].
Zhonghua Nan Ke Xue
; 25(5): 329-332, 2019 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-32216214
5.
Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in China.
BJU Int
; 114(4): 496-502, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25383400
6.
A Phase II trial of dosage escalation of sorafenib in Asian patients with metastatic renal cell carcinoma.
Future Oncol
; 10(12): 1941-51, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25386811
7.
[Hematologic adverse effects in patients with renal cell carcinoma treated with sunitinib].
Zhonghua Yi Xue Za Zhi
; 93(12): 902-5, 2013 Mar 26.
Artículo
en Zh
| MEDLINE | ID: mdl-23863673
8.
[Exploratory analysis of the effect of toxicity of sunitinib on the clinical outcome of patients with advanced renal cell carcinoma].
Zhonghua Yi Xue Za Zhi
; 93(36): 2880-3, 2013 Sep 24.
Artículo
en Zh
| MEDLINE | ID: mdl-24373400
9.
[Efficacy of low dose ketoconazole therapy for Chinese patients with castration resistant prostate cancer].
Zhonghua Yi Xue Za Zhi
; 92(8): 520-3, 2012 Feb 28.
Artículo
en Zh
| MEDLINE | ID: mdl-22490153
10.
Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled Trial.
Eur Urol Oncol
; 5(5): 519-525, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35780048
11.
Comparison of accuracy among three generations of Partin tables in a Chinese cohort.
Can J Urol
; 18(2): 5619-24, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21504650
12.
[Establishment of regression model predicting the probability of the capsular penetration of prostate cancer].
Zhonghua Yi Xue Za Zhi
; 90(42): 2976-9, 2010 Nov 16.
Artículo
en Zh
| MEDLINE | ID: mdl-21211309
13.
[Experiences of open transperitoneal radical nephrectomy for large renal masses].
Zhonghua Yi Xue Za Zhi
; 90(16): 1117-9, 2010 Apr 27.
Artículo
en Zh
| MEDLINE | ID: mdl-20646430
14.
[External validation of the Partin tables 2007 in Chinese prostate cancer patients].
Zhonghua Wai Ke Za Zhi
; 48(19): 1500-3, 2010 Oct 01.
Artículo
en Zh
| MEDLINE | ID: mdl-21176660
15.
[The survival analysis of metastatic prostate cancer].
Zhonghua Wai Ke Za Zhi
; 48(15): 1166-9, 2010 Aug 01.
Artículo
en Zh
| MEDLINE | ID: mdl-21055012
16.
[The survival analysis of the advanced metastatic castration-resistant prostate cancer].
Zhonghua Wai Ke Za Zhi
; 47(22): 1712-4, 2009 Nov 15.
Artículo
en Zh
| MEDLINE | ID: mdl-20137723
17.
Clinical activity of abiraterone plus prednisone in docetaxel-naοve and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer.
Asian J Androl
; 21(2): 131-136, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30560837
18.
Genetic variants in RTEL1 influencing telomere length are associated with prostate cancer risk.
J Cancer
; 10(24): 6170-6174, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31762827
19.
External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer.
Asian J Androl
; 20(2): 184-188, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29111539
20.
Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate.
Mil Med Res
; 9(1): 5, 2022 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35074001